Market cap
₹10 Cr
Recently Viewed
Clear AllBSE: 531043
₹25.01
₹-1.31
(-4.98%)
As on 29-Apr-2026IST
Market cap
₹10 Cr
Revenue (TTM)
₹24 Cr
P/E Ratio
85.4
P/B Ratio
1
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹0 Cr
ROE
5.2 %
ROCE
5.8 %
Industry P/E
48.9
EV/EBITDA
12.1
Debt to Equity
0
Book Value
₹24.8
EPS
₹0.3
Face value
10
Shares outstanding
4,098,400
CFO
₹11.43 Cr
EBITDA
₹9.24 Cr
Net Profit
₹1.53 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Dhanvantri Jeevan
| -0.1 | 4.4 | 2.4 | 25.1 | 19.7 | 29.8 | -2.9 |
|
BSE Healthcare
| 2.8 | 5.2 | 8.2 | 4.9 | 24.7 | 13.9 | 11.2 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Dhanvantri Jeevan
| 17.8 | 63.9 | 2.3 | 4.7 | 149.8 | -40.9 | -53.0 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Dhanvantri Jeevan
|
25.0 | 10.3 | 24.5 | 0.1 | -0.7 | 1.2 | 85.4 | 1.0 |
| 239.9 | 3,798.6 | 1,041.9 | 96.4 | 12.0 | 11.5 | 39.3 | 3.3 | |
| 699.5 | 36,240.0 | 4,461.2 | 397.5 | 13.4 | 9.1 | 110.8 | 7.9 | |
| 442.0 | 13,996.9 | 1,976.2 | 160.7 | 14.1 | 6.7 | 111 | 7.1 | |
| 570.3 | 8,499.0 | 2,478.2 | 24.7 | 8.4 | 4.2 | 448.5 | 6.4 | |
| 403.1 | 3,695.8 | 1,451.5 | 182.9 | 15.5 | 29.2 | 20.2 | 5.3 | |
| 1,239.5 | 8,117.1 | 1,433.4 | 188.7 | 17.4 | 13.8 | 43 | 5.4 | |
| 5,693.8 | 6,239.6 | 1,529.9 | 235.8 | 21.2 | 20.7 | 26.5 | 5.0 | |
| 1,264.2 | 12,796.5 | 1,613.3 | 259.9 | 23.0 | 17.3 | 49.7 | 8.0 | |
| 803.0 | 7,745.4 | 1,089.4 | 165.1 | 17.4 | 10.2 | 46.3 | 4.5 |
Investor Protection Fund now owns 0.51% in RIL
2 min read•By Danish Khanna
Dhanvantri Jeevan Rekha Limited provides medical and health care services in India. The company operates the multi-specialty Dhanvantri hospital in Meerut. Its Dhanvantri Hospital offers diagnostic and therapeutic services, including cardiology,... neurology, respiratory medicine, gastroenterology, gastro surgery, neuro surgery, orthopedic surgery, urology, oral and maxillofaccial surgery, oncology, otorhinolaryngology, pathology, rehabilitation program, and other diagnostic services. The company also operates intensive coronary care units and intensive care units. In addition, it offers services for various breast problems, such as mastalgias, mastopathies, breast lumps, and breast cancer, as well as screening for early breast cancers and training for self-examinations. Dhanvantri Jeevan Rekha Limited was founded in 1993 and is based in Meerut, India. Read more
Incorporated
1993
Chairman
--
Managing Director
Shalini Sharma
Headquarters
Meerut, Uttar Pradesh
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsRESULT FOR THE HALF YEAR ENDING SEPT 2025
14-Nov-2025No News & Announcements are available.
The share price of Dhanvantri Jeevan Rekha Ltd is ₹25.01 (BSE) as of 29-Apr-2026 IST. Dhanvantri Jeevan Rekha Ltd has given a return of 19.65% in the last 3 years.
The P/E ratio of Dhanvantri Jeevan Rekha Ltd is 85.42 times as on 29-Apr-2026, a 75 premium to its peers’ median range of 48.90 times.
The P/B ratio of Dhanvantri Jeevan Rekha Ltd is 1.01 times as on 29-Apr-2026, a 86 discount to its peers’ median range of 7.21 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
16.73
|
0.84
|
|
2024
|
60.76
|
1.07
|
|
2023
|
0.00
|
0.58
|
|
2022
|
13.96
|
0.72
|
|
2021
|
0.00
|
0.34
|
The 52-week high and low of Dhanvantri Jeevan Rekha Ltd are Rs 35.86 and Rs 16.55 as of 29-Apr-2026.
Dhanvantri Jeevan Rekha Ltd has a market capitalisation of ₹ 10 Cr as on 29-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Dhanvantri Jeevan Rekha Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.